NEA Management Company as of June 30, 2025
Portfolio Holdings for NEA Management Company
NEA Management Company holds 32 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 18.6 | $247M | 3.7M | 65.85 | |
| Verona Pharma Sponsered Ads (VRNA) | 16.1 | $214M | 2.3M | 94.58 | |
| Rhythm Pharmaceuticals (RYTM) | 13.8 | $184M | 2.9M | 63.19 | |
| Coursera (COUR) | 8.5 | $113M | 13M | 8.76 | |
| Crispr Therapeutics Namen Akt (CRSP) | 5.8 | $77M | 1.6M | 48.64 | |
| Trevi Therapeutics (TRVI) | 5.4 | $72M | 13M | 5.47 | |
| Savara (SVRA) | 4.2 | $56M | 25M | 2.28 | |
| Oric Pharmaceuticals (ORIC) | 3.1 | $42M | 4.1M | 10.15 | |
| Mbx Biosciences (MBX) | 3.1 | $41M | 3.6M | 11.41 | |
| Monte Rosa Therapeutics (GLUE) | 2.6 | $35M | 7.7M | 4.51 | |
| Aurinia Pharmaceuticals (AUPH) | 2.5 | $34M | 4.0M | 8.47 | |
| Celcuity (CELC) | 2.3 | $31M | 2.3M | 13.35 | |
| Zenas Biopharma (ZBIO) | 2.0 | $27M | 2.7M | 9.69 | |
| Gossamer Bio (GOSS) | 1.7 | $22M | 18M | 1.23 | |
| Neuehealth Com New | 1.4 | $19M | 2.7M | 6.90 | |
| Phathom Pharmaceuticals (PHAT) | 1.4 | $19M | 2.0M | 9.59 | |
| Korro Bio (KRRO) | 1.0 | $14M | 1.1M | 12.49 | |
| Champions Oncology Com New (CSBR) | 1.0 | $13M | 1.7M | 7.37 | |
| CVRX (CVRX) | 0.9 | $12M | 2.0M | 5.88 | |
| Black Diamond Therapeutics (BDTX) | 0.8 | $11M | 4.4M | 2.48 | |
| Inozyme Pharma (INZY) | 0.7 | $9.8M | 2.4M | 4.00 | |
| Senti Biosciences Com New (SNTI) | 0.6 | $8.0M | 3.8M | 2.11 | |
| Omada Health (OMDA) | 0.5 | $6.7M | 364k | 18.30 | |
| Nkarta (NKTX) | 0.4 | $5.9M | 3.6M | 1.66 | |
| Inventiva Sa Ads (IVA) | 0.4 | $4.7M | 1.5M | 3.19 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.3 | $4.1M | 17M | 0.24 | |
| Synlogic Com New (SYBX) | 0.3 | $3.7M | 2.9M | 1.27 | |
| Marker Therapeutics Com New (MRKR) | 0.2 | $2.5M | 1.6M | 1.53 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.1 | $1.1M | 479k | 2.39 | |
| X4 Pharmaceuticals | 0.1 | $949k | 500k | 1.90 | |
| Ikena Oncology (IKNA) | 0.1 | $804k | 600k | 1.34 | |
| Wheels Up Experience Com Cl A (UP) | 0.0 | $114k | 106k | 1.07 |
